New Indication for Slowing Atherosclerosis in Elevated-Cholesterol Patients
Crestor (rosuvastatin calcium) from AstraZeneca has received a new indication as an adjunct to diet to slow the progression of atherosclerosis in adult patients with elevated cholesterol, differentiating it from competitors in the cholesterol-lowering marketplace.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.